Cefotaxime

Description

1. Product Overview

Cefotaxime is a third-generation cephalosporin antibiotic widely used as an active pharmaceutical ingredient (API) in the production of injectable and parenteral formulations. It is highly effective against a broad spectrum of Gram-positive and Gram-negative bacterial infections, making it a critical component in hospital and clinical treatment protocols. The key value proposition lies in its proven therapeutic efficacy, reliable bacterial coverage, and compatibility with modern sterile manufacturing processes. Strategically, cefotaxime remains an essential antibiotic in global healthcare supply chains, supporting demand for high-quality, scalable API sourcing in regulated pharmaceutical markets.

2. Key Specifications & Technical Characteristics

• Chemical Composition:
  • Cefotaxime sodium (C₁₆H₁₆N₅NaO₇S₂)
  • Beta-lactam antibiotic structure
• Purity Level / Grade:
  • Pharmaceutical grade (USP/EP/BP compliant)
  • Typical purity: ≥ 98.0%
  • Endotoxin and sterility compliance as per pharmacopeial standards
• Physical Characteristics:
  • Form: Crystalline powder
  • Color: White to off-white
  • Solubility: Highly soluble in water
  • Hygroscopic under certain conditions
• Packaging Options:
  • Sterile, double-lined pharmaceutical-grade bags
  • Fiber drums (10 kg / 25 kg)
  • Customized packaging for GMP-compliant environments
• Shelf Life:
  • Typically 24–36 months under controlled storage conditions
  • Store in cool, dry, light-protected environments

3. Core Industrial Applications

Primary Industries:

• Pharmaceutical manufacturing
• Biopharmaceutical and formulation companies
• Contract manufacturing organizations (CMOs)
• Healthcare supply chains

Operational Use Cases:

• API for injectable antibiotic formulations
• Production of sterile hospital-grade antibiotics
• Use in combination therapies for severe bacterial infections
• Formulation into powder for reconstitution products

Performance & Cost Advantages:
Cefotaxime offers high clinical efficacy with a broad antibacterial spectrum, reducing the need for multiple antibiotic classes in treatment protocols. Its stability in formulation and compatibility with large-scale sterile manufacturing processes improve production efficiency. Compared to alternative antibiotics, it provides a balanced profile of effectiveness, safety, and cost-efficiency for institutional healthcare use.

4. Competitive Advantages

• Quality Consistency: Manufactured under strict GMP conditions with validated batch-to-batch uniformity
• Supply Reliability: Scalable production capacity ensuring uninterrupted global supply
• Logistics Capability: Temperature-controlled and compliant pharmaceutical distribution network
• Price Competitiveness: Optimized production processes ensuring competitive API pricing
• Sustainability Benefits: Efficient manufacturing practices with controlled waste and emissions
• Technical Documentation: Complete regulatory dossier including DMF, COA, SDS, and stability data available

Positioned as a strategic sourcing solution, cefotaxime ensures pharmaceutical manufacturers secure a reliable, compliant, and cost-effective API for critical antibiotic production.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20MT
• Loading Capacity (MT per container): Approximately 10–15 MT per 20’ container (subject to packaging, regulatory, and pharmaceutical handling requirements)